I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
et al., 2017, Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions., Neuroimage Clin, Vol:13, Pages:9-15
et al., 2017, A discrete event simulation to model the cost-utility of fingolimod and natalizumab in rapidly evolving severe relapsing-remitting multiple sclerosis in the UK., J Med Econ, Pages:1-9
et al., 2016, Intrathecal T-cell clonal expansions in patients with multiple sclerosis, Annals of Clinical and Translational Neurology, Vol:3, ISSN:2328-9503, Pages:422-433
et al., 2016, Neuroinflammation and genesis of affective symptoms in multiple sclerosis: integrating evidence from TSPO PET and resting state FMRI, Bipolar Disorders, Vol:18, ISSN:1398-5647, Pages:84-84
et al., 2016, Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis, Biological Psychiatry, Vol:80, ISSN:0006-3223, Pages:62-72